Cerba Research was one of the first organizations in Europe to offer multispectral multiplex IHC services to pharmaceutical and biotechnology companies. In an era where increased numbers of protein biomarkers, advanced phenotyping, and spatial context are needed on precious samples of limited size, multiplex IHC is the right approach to obtain the most relevant and comprehensive data from tissue samples.
Our multiplex IHC panels are the right tool to understand the sociology (distances between cell populations, tissue infiltration, and advanced phenotyping based on both the expression or absence of expression of biomarkers) of key cell players and biomarkers in the tissue.
Presentation – Putting Multiplex IHC to the Challenge
Reach out to our experts to discover how we can help advance your clinical trialContact Us